In last month, Pharma sector have witnessed huge threat from US FDA as there were more than observations have been done. Entire pharma sector suffered due to this and stocks crashed more than 23-30 percent on an average. Attending the same, Dr. Reddy was marked for inadequate manufacturing standards in their US plant. But shifting three manufacturing units from US back to India is not a one day game for the company. The manufacturing will be on halt till the issue get resolved. This halt surely will be hammering the revenues of the company. But the company management is still favoring that it will get resolved soon and everything will be perfect shortly. For more Visit: Stock Market Tips